Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 235

Pro.com fixes up $33m series B

The home renovation software developer has raised $33m in a round co-led by Redfin, Goldman Sachs and WestRiver, taking its total funding to more than $50m.

Jan 21, 2019

ScaleFactor to grow with $30m series B

The Citi Ventures-backed bookkeeping software provider has increased its total funding to almost $43m in a Bessemer Venture Partners-led round.

Jan 21, 2019

Innovaccer gets $35m funding injection

Microsoft’s M12 subsidiary led an extension that brought Innovaccer’s series B round to a $35m close, and the company’s overall funding to $51m.

Jan 21, 2019

HyperScience hits series B round with $30m

QBE and TD Ameritrade have taken part in a series B round that will be used to develop the company's artificial intelligence-based data entry technology.

Jan 21, 2019

Corporate venturing deal net: 14-18 January 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jan 18, 2019

Wiliot picks up $30m signal

The bluetooth tag maker is now valued at $120m following a series B round featuring Qualcomm Ventures, Merck Group, Amazon, Samsung Ventures and Avery Dennison.

Jan 16, 2019

Measurabl builds out series B round

The real estate data management platform has closed an $18.7m round following commitments from Berman Enterprises, DivcoWest, Exelon and S&P Global.

Jan 16, 2019

Lambda School passes $30m exam

The computer science academy has raised series B funding at a $150m valuation from investors including GV, three months after closing its series A round.

Jan 14, 2019

Beta Bionics bets on corporates in $63m round

Zealand and Dexom has contributed to a $13m extension to the artificial pancreas developer's series B round, which also includes Novo Nordisk.

Jan 14, 2019

Biond Biologics forms corporate bonds to raise $17m

Celgene has taken part in a Harel Insurance Finance-led series B round that will fund the progress of Biond's lead immuno-oncology drug into clinical trials.

Jan 14, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here